Regenerative medicine is one of the most active research areas in modern medicine, and the findings so far are genuinely exciting. They're also, in many cases, early. This page summarizes what's actually been studied — organized by how far along the research is — so you can tell the difference between "this is an approved therapy" and "this is a promising early signal."
Established Use: Blood Disorders
Hematopoietic Stem Cell Transplants (Bone Marrow Transplants)
This is the one genuinely established, FDA-approved use of stem cell therapy. For decades, doctors have used blood-forming stem cells — sourced from bone marrow, peripheral blood, or umbilical cord blood — to treat leukemia, lymphoma, neuroblastoma, multiple myeloma, and other blood-related diseases. These transplants either replace cells damaged by chemotherapy or use a donor's immune system to fight certain cancers.
Active Research: Graft-Versus-Host Disease (GvHD)
Graft-versus-host disease is a serious complication that can occur after a bone marrow or cord blood transplant, where the donor's immune cells attack the recipient's own tissues. It affects roughly half of transplant patients and can be severe. Standard treatment with steroids works only 30–50% of the time.
Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs) for Steroid-Resistant GvHD
Several published case series have reported meaningful improvement in patients with severe GvHD who didn't respond to standard steroid treatment. In one frequently cited series, two children with severe, treatment-resistant GvHD showed complete symptom resolution within days of receiving WJ-MSC infusions. A larger study of 24 patients found skin and oral symptoms improved in 56–100% of cases. These are genuinely encouraging results — but they come from small, mostly uncontrolled case series, not the large randomized controlled trials needed for FDA approval. Multiple formal clinical trials are now underway.
Active Research: Wound Healing & Skin Aesthetics
This is currently the most heavily marketed application of exosome research, and also one of the least clinically proven. Laboratory and animal studies show real promise; human clinical evidence remains very limited.
Exosomes for Skin Rejuvenation and Wound Healing
In laboratory studies, exosomes derived from adipose stem cells and umbilical cord tissue have improved fibroblast migration, increased collagen production, and reduced markers of cellular aging in skin cells. A small number of human clinical studies (fewer than 20 worldwide) have tested topical exosome products on facial skin and post-procedure healing, generally reporting improvements — but these studies are often fewer than 60 participants, and there's no agreed-upon standard for what makes a quality exosome product.
Endogenous Stem Cell Stimulation (Defensins)
A different approach skips external exosomes and instead tries to activate the skin's own dormant stem cells using signaling proteins called defensins. One small randomized controlled trial (30 participants) found a defensin-containing product produced statistically significant improvement in wrinkles, pore appearance, and skin thickness compared to a control product — though this is based on a single, small trial.
Active Research: Other Conditions Under Investigation
Clinical trials are currently exploring mesenchymal stem cell therapy for:
- Knee osteoarthritis (injected directly into the joint)
- Chronic spinal cord injury
- Amyotrophic lateral sclerosis (ALS)
- Heart function after a heart attack (ischemic cardiomyopathy)
- Erectile dysfunction in patients with diabetes
- Non-healing diabetic foot ulcers
As of this writing, these are registered, active clinical trials — not approved treatments. If you see any of these conditions mentioned alongside a current treatment offer, ask directly whether the treatment is part of a registered clinical trial or being offered outside of one.
Active Research: Cancer Diagnosis
Separately from regenerative therapy, exosomes are being studied as a diagnostic tool — since tumors shed exosomes into blood and other fluids, researchers are exploring whether analyzing these "liquid biopsies" could help detect cancer earlier or track how well a treatment is working. This diagnostic application is a distinct research area from using exosomes as regenerative treatment, and is further along in some respects, though still primarily in research settings.
How to Read Regenerative Medicine Research
Case reports and small studies can show real, encouraging signals — but they can't rule out placebo effects, and results don't always hold up in larger trials. "Active clinical trial" means a treatment is being formally tested, not that it's an approved standard of care. Animal and lab research is an essential first step, but a substantial percentage of preclinical findings never work the same way in humans.